Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Bischoff

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Archiv Fur Toxikologie|January 1, 1973
[Clinical course and therapy of a successfully treated severe bromisovalerinylcarbamide, methaqualone, and meprobamate poisoning in a 12-year-old child]F Schindera, R Gädeke, C Ross, et al.
Der Unfallchirurg|April 29, 1998
[Clinical effects of supplemental enteral nutrition solution in severe polytrauma]L Bastian, A Weimann, W Bischoff, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1991
An assessment of temafloxacin in the treatment of chronic bacterial prostatitisK G Naber, J B Boerema, W Bischoff, et al.
NPJ Primary Care Respiratory Medicine|May 1, 2019
Age- and sex-specific prevalence of chronic comorbidity in adult patients with asthma: A real-life studyMathijs Veenendaal, Janine A M Westerik, Lisette van den Bemt, et al.
International Journal of Antimicrobial Agents|March 24, 2004
Gatifloxacin 200 mg or 400 mg once daily is as effective as ciprofloxacin 500 mg twice daily for the treatment of patients with acute pyelonephritis or complicated urinary tract infectionsK G Naber, A Bartnicki, W Bischoff, et al.
Cancer Treatment Reviews|September 1, 1983
Treatment of small cell lung cancer by different chemotherapy regimesC Gropp, K Havemann, A Liesenfeld, et al.
NPJ Primary Care Respiratory Medicine|April 5, 2018
'Exacerbation-free time' to assess the impact of exacerbations in patients with chronic obstructive pulmonary disease (COPD): a prospective observational studyL M Boer, E W Bischoff, X Borgijink, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 24, 2018
Validation of ACCESS: an automated tool to support self-management of COPD exacerbationsLonneke M Boer, Maarten van der Heijden, Nathalie Me van Kuijk, et al.
NPJ Primary Care Respiratory Medicine|September 9, 2020
Comparing health status between patients with COPD in primary, secondary and tertiary careMieke M de Klein, Jeannette B Peters, Alex J van 't Hul, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Archiv Fur Toxikologie|January 1, 1973
[Clinical course and therapy of a successfully treated severe bromisovalerinylcarbamide, methaqualone, and meprobamate poisoning in a 12-year-old child]F Schindera, R Gädeke, C Ross, et al.
Der Unfallchirurg|April 29, 1998
[Clinical effects of supplemental enteral nutrition solution in severe polytrauma]L Bastian, A Weimann, W Bischoff, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1991
An assessment of temafloxacin in the treatment of chronic bacterial prostatitisK G Naber, J B Boerema, W Bischoff, et al.
NPJ Primary Care Respiratory Medicine|May 1, 2019
Age- and sex-specific prevalence of chronic comorbidity in adult patients with asthma: A real-life studyMathijs Veenendaal, Janine A M Westerik, Lisette van den Bemt, et al.
International Journal of Antimicrobial Agents|March 24, 2004
Gatifloxacin 200 mg or 400 mg once daily is as effective as ciprofloxacin 500 mg twice daily for the treatment of patients with acute pyelonephritis or complicated urinary tract infectionsK G Naber, A Bartnicki, W Bischoff, et al.
Cancer Treatment Reviews|September 1, 1983
Treatment of small cell lung cancer by different chemotherapy regimesC Gropp, K Havemann, A Liesenfeld, et al.
NPJ Primary Care Respiratory Medicine|April 5, 2018
'Exacerbation-free time' to assess the impact of exacerbations in patients with chronic obstructive pulmonary disease (COPD): a prospective observational studyL M Boer, E W Bischoff, X Borgijink, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 24, 2018
Validation of ACCESS: an automated tool to support self-management of COPD exacerbationsLonneke M Boer, Maarten van der Heijden, Nathalie Me van Kuijk, et al.
NPJ Primary Care Respiratory Medicine|September 9, 2020
Comparing health status between patients with COPD in primary, secondary and tertiary careMieke M de Klein, Jeannette B Peters, Alex J van 't Hul, et al.
Pageof 7